Columbus, OH, United States of America

Su-Lin Lee

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Ohio State University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su-Lin Lee. Retrieved from https://idiyas.com/inventor/su-lin-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Su-Lin Lee: Innovator in Cancer Treatment

Introduction

Su-Lin Lee is a prominent inventor based in Columbus, OH, who has made significant contributions to the field of cancer treatment. As a dedicated researcher at The Ohio State University, she focuses on developing innovative solutions to combat cancer through her work on integrin-linked kinase inhibitors.

Latest Patents

Su-Lin Lee holds a patent for integrin-linked kinase inhibitors. This patent describes a number of compounds and their use in a method for treating or preventing cancer in a subject. The pharmaceutical composition includes a compound of formula I or a pharmaceutically acceptable salt thereof. These compounds can also be utilized to inhibit integrin-linked kinase in a cell, which has a notable effect on the Akt signaling pathway.

Career Highlights

Throughout her career, Su-Lin Lee has demonstrated a strong commitment to advancing cancer research. Her work has not only contributed to the scientific community but has also provided hope for patients battling cancer. With her innovative approach, she continues to explore new avenues for treatment.

Collaborations

Su-Lin Lee collaborates with esteemed colleagues, including Ching-Shih Chen and Samuel K Kulp. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.

Conclusion

Su-Lin Lee's work in the field of cancer treatment exemplifies the impact of innovative research on healthcare. Her dedication to developing integrin-linked kinase inhibitors showcases her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…